Novartis tops 2010 MM&M All-Stars list

Share this article:
Novartis is Medical Marketing & Media's Company of the Year, based on its bountiful pipeline, well-diversified business and a spate of recent approvals.

Also among our 2010 All-Stars picks: Euro RSCG Life, for Agency/Network of the Year; AstraZeneca's Symbicort for Large Pharma Marketing Team of the Year; Shire's Vyvanse for Small Pharma Marketing Team of the Year; and HealthiNation, for Media Brand of the Year.

The annual MM&M All-Stars feature, included in our January issue, honors the MM&M editorial team's estimation of which industry players outperformed their peers over the past 12 months and are best positioned going into the new year. We take into account financial performance, innovation, ability to overcome adversity and reputation, among other factors.

You can find all of our 2010 All-Stars picks here
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.